Price T Rowe Associates Inc Stereotaxis, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 80,012 shares of STXS stock, worth $175,226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,012
Previous 76,199
5.0%
Holding current value
$175,226
Previous $156,000
17.31%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding STXS
# of Institutions
92Shares Held
41.8MCall Options Held
217KPut Options Held
4.1K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30 Million8.48% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.13MShares$9.04 Million5.1% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.76 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$7.61 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.79MShares$6.11 Million4.96% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $164M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...